Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Top 10 APTA Reports, Guidelines, and Advisories of 2023

Jan 2, 2024/Roundup

APTA resources covered a lot of ground, including clinical guidelines, coding tips, and a groundbreaking report on physical therapy's value.

Clinical and Research Readiness for Spinal Muscular Atrophy: The Time Is Now for Knowledge Translation

Jan 24, 2023/Podcast

Spinal muscular atrophy resources need knowledge translation.

Digital Health Technology Outside the U.S.

Sep 20, 2022/Article

As digital health technology continues to evolve and incorporate into clinical care, APTA has identified resources from the international community that can enhance your digital literacy.

Tools To Advance Your Professionalism

Use these resources to understand professionalism and support your ongoing development.

APTA Physical Therapist Centralized Application Service

PTCAS, the physical therapist centralized application service provided by APTA, allows you to apply to multiple physical therapist education programs with one application and set of resources.

A Closer Look: Productivity Measurement in Acute Care Physical Therapy

Jun 25, 2024/Resource

In response to the 2021 APTA House of Delegates position and charge related to productivity standards, an APTA Association Leadership Scholars paper was developed based on a survey distributed to members of APTA Acute Care in June of 2022.

Physical Activity Guidelines for Americans, 2nd edition

Jan 1, 2018/CPG

The second edition of the Physical Activity Guidelines for Americans provides scientific guidance to help people ages 3 years and older improve their health through participation in regular physical activity.

American Academy of Orthopaedic Surgeons: Management of Osteoarthritis of the Knee (Non-Arthroplasty)

Aug 31, 2021/CPG

This guideline focuses specifically on the non-arthroplasty treatment of osteoarthritis of the knee. It does not cover osteoarthritis of other joints, rheumatoid arthritis, or other inflammatory disorders. This replaces 2013 appropriate use criteria.